Rhabdomyolysis in isoniazid poisoning.
BACKGROUND
Rhabdomyolysis is one of the reported complications of isoniazid poisoning, but relevant data are limited.


METHODS
A retrospective study was conducted on isoniazid poisoning cases seen at the Philippine General Hospital over 5 years (1992-1997). Patients excluded from the study were those who coingested other substances, including hepatotoxic and nephrotoxic drugs, those with underlying medical illnesses, and those without creatine phosphokinase muscle fraction determinations.


RESULTS
Out of the 270 cases of isoniazid poisoning, 52 patient records were reviewed. Common clinical manifestations were seizures (100%), depressed sensorium (53%), and vomiting (45%). Laboratory results showed leukocytosis (74.5%), metabolic acidosis (29%), and impaired liver function tests (21%). Creatine phosphokinase muscle fraction was elevated in 59.6% of cases, beginning at a dose of 2.4 g. Values peaked on days 5 and 6 and declined on days 7 and 8. Statistically significant correlations were observed for the elevation of creatine phosphokinase muscle fraction with the duration/amount of drug ingested and the frequency of seizure. No correlation was observed between the frequency of seizures and elevated creatine phosphokinase muscle fraction nor between the time delay in consultation and elevation of creatine phosphokinase muscle fraction.


CONCLUSIONS
The incidence of rhabdomyolysis in isoniazid poisoning was 3/100 cases a year. The findings suggesting its direct toxic effect on the muscles may not be clinically relevant.
Panganiban
L R
LR
National Poison Control and Information Service, University of the Philippines-College of Medicine, Philippine General Hospital, Manila. lcrp@kulog.upm.edu.ph
Makalinao
I R
IR
Corte-Maramba
N P
NP
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D002648:Child; D002675:Child, Preschool; D003402:Creatine Kinase / Q000097:blood; D052283:Creatine Kinase, MM Form; D005260:Female; D006769:Hospitals, General; D006801:Humans; D007223:Infant; D007527:Isoenzymes / Q000097:blood; D007538:Isoniazid / Q000506:poisoning*; D008297:Male; D008875:Middle Aged; D010679:Philippines / Q000453:epidemiology; D011041:Poisoning / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D012189:Retrospective Studies; D012206:Rhabdomyolysis / Q000139:chemically induced*; D012640:Seizures / Q000139:chemically induced; D013405:Suicide; D016896:Treatment Outcome
D007527:Isoenzymes; D003402:Creatine Kinase; D052283:Creatine Kinase, MM Form; D007538:Isoniazid